Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/protein kinase Cμ

被引:190
作者
Matthews, SA
Rozengurt, E
Cantrell, D
机构
[1] Imperial Canc Res Fund, Lymphocyte Activat Lab, London WC2A 3PX, England
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA
关键词
D O I
10.1074/jbc.274.37.26543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the serine kinase protein kinase D (PKD)/PKC mu is controlled by the phosphorylation of two serine residues within its activation loop via a PKC-dependent signaling cascade. In this study we have identified the C-terminal serine 916 residue as an in vivo phosphorylation site within active PKD/PKC mu. An antibody that recognized PKD/PKC mu proteins specifically phosphorylated on the serine 916 residue was generated and used to show that phosphorylation of Ser-916 is induced by phorbol ester treatment of cells. Thus, the pS916 antibody is a useful tool to study the regulation of PKD/PKC mu activity in vivo. Antigen receptor ligation of T and B lymphocytes also induced phosphorylation of the serine 916 residue of PKD/PKC mu. Furthermore the regulatory Fc gamma RIIB receptor, which mediates vital negative feedback signals to the B cell antigen receptor complex, inhibited the antigen receptor-induced activation and serine 916 phosphorylation of PKD/PKC mu. The degree of serine 916 phosphorylation during lymphocyte activation and inhibition exactly correlated with the activation status of PKD/PKC mu. Moreover, using different mutants of PKD/PKC mu, we show that serine 916 is not trans-phosphorylated by an upstream kinase but is rather an autophosphorylation event that occurs following activation of PKD/PKC mu.
引用
收藏
页码:26543 / 26549
页数:7
相关论文
共 32 条
[1]   Rapid activation of the novel serine/threonine protein kinase, protein kinase D by phorbol esters, angiotensin II and PDGF-BB in vascular smooth muscle cells [J].
Abedi, H ;
Rozengurt, E ;
Zachary, I .
FEBS LETTERS, 1998, 427 (02) :209-212
[2]   ACTIVATION OF JAK KINASES AND STAT PROTEINS BY INTERLEUKIN-2 AND INTERFERON-ALPHA, BUT NOT THE T-CELL ANTIGEN RECEPTOR, IN HUMAN T-LYMPHOCYTES [J].
BEADLING, C ;
GUSCHIN, D ;
WITTHUHN, BA ;
ZIEMIECKI, A ;
IHLE, JN ;
KERR, IM ;
CANTRELL, DA .
EMBO JOURNAL, 1994, 13 (23) :5605-5615
[3]  
CZERNIK AJ, 1991, METHOD ENZYMOL, V201, P264
[4]   PROTEIN-KINASE-C - A QUESTION OF SPECIFICITY [J].
DEKKER, LV ;
PARKER, PJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (02) :73-77
[5]   Protein kinase C μ is negatively regulated by 14-3-3 signal transduction proteins [J].
Hausser, A ;
Storz, P ;
Link, G ;
Stoll, H ;
Liu, YC ;
Altman, A ;
Pfizenmaier, K ;
Johannes, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9258-9264
[6]  
HESCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281
[7]   PROTEIN-KINASE-C ISOENZYMES - DIVERGENCE IN SIGNAL TRANSDUCTION [J].
HUG, H ;
SARRE, TF .
BIOCHEMICAL JOURNAL, 1993, 291 :329-343
[8]   Protein kinase D activation by mutations within its pleckstrin homology domain [J].
Iglesias, T ;
Rozengurt, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :410-416
[9]   Identification of in vivo phosphorylation sites required for protein kinase D activation [J].
Iglesias, T ;
Waldron, RT ;
Rozengurt, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (42) :27662-27667
[10]  
JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140